The field of pediatric neuro-oncology research is considered to be in the “rare disease” category. How do we tell the thousands of patients newly diagnosed this year that they need to wait? One component of our Making Headway Foundation mission is to advance toward better treatments and a cure. We will try to forward articles of interest on recent advances in this field. If you have any news to report, let us know!
In the meantime, here is something which may interest you.
Ependymoma is an aggressive type of brain cancer that primarily affects infants. Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have carried out a comprehensive molecular analysis of these tumors. Here is an article on their findings.
Making Headway has not evaluated the information provided here. It is presented for informational purposes only.